Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-11 Purchase |
2024-03-11 3:27 pm |
Harpoon Therapeutics Inc. | HARP | Merck & Co. Inc. MERCK SHARP & DOHME LLC 10% Owner |
21,397,205 | $23 | $492,135,715 | 1,000 (Indirect) |
View |
| 2024-02-14 Sale |
2024-02-15 4:03 pm |
Merck & Co. Inc. | MRK | Litchfield Caroline EVP & CFO |
38,291 | $125.5 | $4,805,521 | 50,908 (Direct) |
View |
| 2024-02-13 Sale |
2024-02-15 4:01 pm |
Merck & Co. Inc. | MRK | Davis Robert M Chairman, CEO & President |
235,021 | $125.69 | $29,538,998 | 709,888 (Direct) |
View |
| 2024-02-13 Sale |
2024-02-14 4:03 pm |
Merck & Co. Inc. | MRK | Romanelli Joseph President, Human Health Int?l |
1,000 | $124.89 | $124,888 | 19,569 (Direct) |
View |
| 2024-02-09 Sale |
2024-02-12 4:03 pm |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
14,702 | $125.5 | $1,845,083 | 46,242 (Direct) |
View |
| 2024-02-07 Sale |
2024-02-08 4:04 pm |
Merck & Co. Inc. | MRK | Williams David Michael EVP,Chief Info&Digital Officer |
1,451 | $127.57 | $185,108 | 19,812 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 4:01 pm |
Merck & Co. Inc. | MRK | Oosthuizen Johannes Jacobus President, U.S. Market |
18,959 | $127.17 | $2,411,111 | 44,616 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-02 4:07 pm |
Merck & Co. Inc. | MRK | MIZELL STEVEN EVP, Chief HR Officer |
50,694 | $126.65 | $6,420,349 | 45,707 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-02 4:05 pm |
Merck & Co. Inc. | MRK | Zachary Jennifer EVP, General Counsel |
49,499 | $126.97 | $6,284,779 | 67,893 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-05-02 Exercise |
2024-05-02 4:29 pm |
2024-05-02 2026-05-02 |
Merck & Co. Inc. | MRK | Romanelli Joseph President, Human Health Int?l |
2,262 | $0 | 54,869 (Direct) |
View |
| 2024-04-30 Option Award |
2024-05-02 4:29 pm |
2025-04-30 2027-04-30 |
Merck & Co. Inc. | MRK | Romanelli Joseph President, Human Health Int?l |
29,629 | $0 | 54,869 (Direct) |
View |
| 2024-05-02 Tax Withholding |
2024-05-02 4:29 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Romanelli Joseph President, Human Health Int?l |
1,115 | $128.8 | 54,869 (Direct) |
View |
| 2024-05-02 Exercise |
2024-05-02 4:29 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Romanelli Joseph President, Human Health Int?l |
2,262 | $128.8 | 54,869 (Direct) |
View |
| 2024-04-30 Option Award |
2024-05-02 4:25 pm |
2025-04-30 2027-04-30 |
Merck & Co. Inc. | MRK | Larson Betty D EVP, Chief HR Officer |
123,699 | $0 | 123,699 (Direct) |
View |
| 2024-05-02 Exercise |
2024-05-02 4:23 pm |
2024-05-02 2026-05-02 |
Merck & Co. Inc. | MRK | Smart Dalton SVP Fin. - Global Controller |
381 | $0 | 12,105 (Direct) |
View |
| 2024-04-30 Option Award |
2024-05-02 4:23 pm |
2025-04-30 2027-04-30 |
Merck & Co. Inc. | MRK | Smart Dalton SVP Fin. - Global Controller |
8,424 | $0 | 12,105 (Direct) |
View |
| 2024-05-02 Tax Withholding |
2024-05-02 4:23 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Smart Dalton SVP Fin. - Global Controller |
131 | $128.8 | 12,105 (Direct) |
View |
| 2024-05-02 Exercise |
2024-05-02 4:23 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Smart Dalton SVP Fin. - Global Controller |
381 | $128.8 | 12,105 (Direct) |
View |
| 2024-04-30 Option Award |
2024-05-02 4:22 pm |
2025-04-30 2034-04-29 |
Merck & Co. Inc. | MRK | Guindo Chirfi Chief Marketing Officer |
29,297 | $0 | 50,104 (Direct) |
View |
| 2024-04-30 Option Award |
2024-05-02 4:20 pm |
2025-04-30 2034-04-29 |
Merck & Co. Inc. | MRK | Downing Cristal N Chief Comm. & Public Afrs Ofcr |
15,234 | $0 | 15,234 (Direct) |
View |
| 2024-04-30 Option Award |
2024-05-02 4:19 pm |
2025-04-30 2034-04-29 |
Merck & Co. Inc. | MRK | Zachary Jennifer EVP, General Counsel |
35,156 | $0 | 64,390 (Direct) |
View |
| 2024-04-30 Option Award |
2024-05-02 4:17 pm |
2025-04-30 2034-04-29 |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
65,625 | $0 | 112,027 (Direct) |
View |
| 2024-04-30 Option Award |
2024-05-02 4:15 pm |
2025-04-30 2034-04-29 |
Merck & Co. Inc. | MRK | Oosthuizen Johannes Jacobus President, U.S. Market |
20,508 | $0 | 43,867 (Direct) |
View |
| 2024-04-30 Option Award |
2024-05-02 4:14 pm |
2025-04-30 2034-04-29 |
Merck & Co. Inc. | MRK | Davis Robert M Chairman, CEO & President |
181,641 | $0 | 529,968 (Direct) |
View |
| 2024-04-30 Option Award |
2024-05-02 4:13 pm |
2025-04-30 2034-04-29 |
Merck & Co. Inc. | MRK | Chattopadhyay Sanat Exe V-P & Pres. MMD |
38,672 | $0 | 195,864 (Direct) |
View |
| 2024-04-30 Option Award |
2024-05-02 4:11 pm |
2025-04-30 2034-04-29 |
Merck & Co. Inc. | MRK | Williams David Michael EVP,Chief Info&Digital Officer |
16,406 | $0 | 36,282 (Direct) |
View |
| 2024-04-30 Option Award |
2024-05-02 4:09 pm |
2025-04-30 2034-04-29 |
Merck & Co. Inc. | MRK | Klobuchar Michael A EVP - Chief Strategy Officer |
20,508 | $0 | 45,256 (Direct) |
View |
| 2024-04-30 Option Award |
2024-05-02 4:07 pm |
2025-04-30 2034-04-29 |
Merck & Co. Inc. | MRK | Litchfield Caroline EVP & CFO |
49,805 | $0 | 100,713 (Direct) |
View |
| 2024-04-30 Option Award |
2024-05-02 4:05 pm |
2027-04-30 2027-04-30 |
Merck & Co. Inc. | MRK | DeLuca Richard R. EVP&Pres, Merck Animal Heallth |
60,716 | $0 | 198,546 (Direct) |
View |
| 2024-03-28 Option Award |
2024-03-29 4:18 pm |
N/A N/A |
Merck & Co. Inc. | MRK | WENDELL PETER C Director |
227 | $131.95 | 125,753 (Direct) |
View |
| 2024-03-28 Option Award |
2024-03-29 4:16 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Seidman Christine E Director |
62 | $131.95 | 13,020 (Direct) |
View |
| 2024-03-28 Option Award |
2024-03-29 4:14 pm |
N/A N/A |
Merck & Co. Inc. | MRK | GLOCER THOMAS H Director |
341 | $131.95 | 98,460 (Direct) |
View |
| 2024-03-28 Option Award |
2024-03-29 4:12 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Coe Mary Ellen Director |
227 | $131.95 | 21,060 (Direct) |
View |
| 2024-02-14 Exercise |
2024-02-15 4:03 pm |
2016-05-01 2025-04-30 |
Merck & Co. Inc. | MRK | Litchfield Caroline EVP & CFO |
38,291 | $0 | 50,908 (Direct) |
View |
| 2024-02-14 Exercise |
2024-02-15 4:03 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Litchfield Caroline EVP & CFO |
38,291 | $58.08 | 50,908 (Direct) |
View |
| 2024-02-13 Exercise |
2024-02-15 4:01 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Davis Robert M Chairman, CEO & President |
193,512 | $73.73 | 709,888 (Direct) |
View |
| 2024-02-13 Exercise |
2024-02-15 4:01 pm |
2021-05-01 2030-04-30 |
Merck & Co. Inc. | MRK | Davis Robert M Chairman, CEO & President |
235,021 | $0 | 709,888 (Direct) |
View |
| 2024-02-13 Exercise |
2024-02-15 4:01 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Davis Robert M Chairman, CEO & President |
41,509 | $75.36 | 709,888 (Direct) |
View |
| 2024-02-09 Exercise |
2024-02-12 4:03 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
14,702 | $62.07 | 46,242 (Direct) |
View |
| 2024-02-09 Exercise |
2024-02-12 4:03 pm |
2018-05-05 2027-05-04 |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
14,702 | $0 | 46,242 (Direct) |
View |
| 2024-02-02 Exercise |
2024-02-05 4:01 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Oosthuizen Johannes Jacobus President, U.S. Market |
7,045 | $73.73 | 44,616 (Direct) |
View |
| 2024-02-02 Exercise |
2024-02-05 4:01 pm |
2021-05-01 2030-04-30 |
Merck & Co. Inc. | MRK | Oosthuizen Johannes Jacobus President, U.S. Market |
20,937 | $0 | 44,616 (Direct) |
View |
| 2024-02-02 Exercise |
2024-02-05 4:01 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Oosthuizen Johannes Jacobus President, U.S. Market |
6,773 | $75.36 | 44,616 (Direct) |
View |
| 2024-02-02 Exercise |
2024-02-05 4:01 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Oosthuizen Johannes Jacobus President, U.S. Market |
7,119 | $87.1 | 44,616 (Direct) |
View |
| 2024-02-02 Exercise |
2024-02-02 4:07 pm |
N/A N/A |
Merck & Co. Inc. | MRK | MIZELL STEVEN EVP, Chief HR Officer |
32,170 | $73.73 | 45,707 (Direct) |
View |
| 2024-02-02 Exercise |
2024-02-02 4:07 pm |
2019-10-30 2028-10-29 |
Merck & Co. Inc. | MRK | MIZELL STEVEN EVP, Chief HR Officer |
32,994 | $0 | 45,707 (Direct) |
View |
| 2024-02-02 Exercise |
2024-02-02 4:07 pm |
N/A N/A |
Merck & Co. Inc. | MRK | MIZELL STEVEN EVP, Chief HR Officer |
824 | $70.71 | 45,707 (Direct) |
View |
| 2024-02-02 Exercise |
2024-02-02 4:05 pm |
2023-05-03 2032-05-02 |
Merck & Co. Inc. | MRK | Zachary Jennifer EVP, General Counsel |
19,417 | $0 | 67,893 (Direct) |
View |
| 2024-02-02 Exercise |
2024-02-02 4:05 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Zachary Jennifer EVP, General Counsel |
19,417 | $87.1 | 67,893 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 4:17 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Oosthuizen Johannes Jacobus President, U.S. Market |
3,133 | $119.43 | 21,349 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 4:16 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Smart Dalton SVP Fin. - Global Controller |
2,661 | $119.43 | 2,667 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 4:14 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Williams David Michael EVP,Chief Info&Digital Officer |
10,196 | $119.43 | 21,263 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 4:13 pm |
N/A N/A |
Merck & Co. Inc. | MRK | MIZELL STEVEN EVP, Chief HR Officer |
18,384 | $119.43 | 41,319 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 4:11 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Zachary Jennifer EVP, General Counsel |
23,298 | $119.43 | 59,140 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 4:10 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Li Dean Y Executive VP & President, MRL |
25,760 | $119.43 | 46,242 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 4:08 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Davis Robert M Chairman, CEO & President |
76,510 | $119.43 | 348,327 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 4:06 pm |
N/A N/A |
Merck & Co. Inc. | MRK | DeLuca Richard R. EVP&Pres, Merck Animal Heallth |
23,296 | $119.43 | 137,013 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 4:05 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Chattopadhyay Sanat Exe V-P & Pres. MMD |
26,716 | $119.43 | 157,192 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 4:03 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Litchfield Caroline EVP & CFO |
19,208 | $119.43 | 50,908 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 4:01 pm |
N/A N/A |
Merck & Co. Inc. | MRK | Klobuchar Michael A EVP - Chief Strategy Officer |
3,896 | $119.43 | 24,667 (Direct) |
View |
Ownership |
2024-01-17 5:52 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | Merck & Co. Inc. MERCK SHARP & DOHME LLC 10% Owner |
0 | $0 | 0 (Indirect) |
View |